Ilex Medical Ltd (TLV:ILX)

Israel flag Israel · Delayed Price · Currency is ILS · Price in ILA
6,415.00
-4.00 (-0.06%)
At close: Dec 4, 2025
-21.05%
Market Cap 717.72M
Revenue (ttm) 915.05M
Net Income (ttm) 43.64M
Shares Out 11.19M
EPS (ttm) 3.90
PE Ratio 14.77
Forward PE n/a
Dividend 1.22 (1.90%)
Ex-Dividend Date Apr 7, 2025
Volume 448
Average Volume 933
Open 6,419.00
Previous Close 6,419.00
Day's Range 6,363.00 - 6,419.00
52-Week Range 5,643.00 - 8,499.00
Beta 0.00
RSI 40.40
Earnings Date Nov 25, 2025

About Ilex Medical

Ilex Medical Ltd engages in import, marketing, distribution, and sale of diagnostic products, kits, and consumables in Israel, South Africa, and internationally. The company offers microbiology, chemistry, molecular biology, immunochemistry, and blood banking solutions. It also offers coagulation, hematology, blood gases, bilirubin, biomarkers, fertility, cellular medicine, occult blood, calprotectin, LIS, urine microscopy, osmolarity, and genetic laboratory services. In addition, the company offers medical automation solutions for microbiology... [Read more]

Industry Medical Devices
Sector Healthcare
Founded 1977
Employees 178
Stock Exchange Tel Aviv Stock Exchange
Ticker Symbol ILX
Full Company Profile

Financial Performance

In 2024, Ilex Medical's revenue was 920.37 million, an increase of 0.45% compared to the previous year's 916.25 million. Earnings were 38.98 million, a decrease of -23.39%.

Financial Statements

News

There is no news available yet.